Episode Details

Life sciences cloud software company Veeva's origins as a highly decentralized organization and its early adoption of video conferencing paid off when Covid-19 forced the switch to remote work. The business was able to help speed up the vaccine pipeline. Co-founder and director, HBS alumnus Matt Wallach, talks about the firm’s post-Covid work-from-anywhere strategy, its embrace of the multi-stakeholder public benefit corporation model, and why it foregoes non-compete clauses as it aims to foster employees’ careers.